Skip to content

Orthotic Treatment of Diabetic Foot Ulcers

Orthotic Treatment of Diabetic Foot Ulcers: Patient Adherence to Prescribed Wear and Effectiveness of Treatment

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05094037
Enrollment
18
Registered
2021-10-26
Start date
2023-12-04
Completion date
2026-03-31
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Brief summary

The United States Department of Veterans Affairs spends an estimated $1.5 billion a year on healthcare for patients with diabetes. The prevalence and complications of diabetes increase with age. Therefore, with the aging of the US and Veteran populations, there is an expectation of increased healthcare costs associated with treating diabetes and the associated complications of this disorder. One common complication is the diabetic foot ulcer. Diabetic foot ulcers are expensive to treat, can take a long time to heal and result in a decrease in patient quality of life. Patients remain susceptible to developing more foot ulcers over time. The goal of this project is to reduce the time it takes to heal a diabetic foot ulcer, increase the time between episodes of ulceration and improve the quality of life for diabetic foot ulcer patients.

Interventions

DEVICERemovable cam walker boot

Standard of care device given to diabetic foot ulcer patients.

OTHERCounseling

Additional education, counseling and encouragement of use of the orthosis beyond the current standard of care.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Veteran patients prescribed an orthotic walking boot for treatment of their diabetic foot ulcer will be eligible to participate in the study.

Exclusion criteria

* Veteran patients with amputation proximal to the tarsometatarsal joint, with a Meggitt-Wagner score of 4 or more, with severe infection, with non-ambulatory status or without palpable pedal pulse will be excluded * All patients will be screened for severe cognitive impairment with the 15 point Brief Interview for Mental Status (BIMS) * scores between 12 and 8 will indicate need for extra efforts to support comprehension of instructions, and patients with scores of 7 or less will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Orthosis wear-timeAt each clinic visit through study completion, an average of 8 monthsThe total time that the orthosis has been worn between clinic visits.
Foot ulcer sizeAt each clinic visit through study completion, an average of 8 monthsSize of the diabetic foot ulcer.
Foot ulcer healing statusAt each clinic visit through study completion, an average of 8 monthsStatus of the diabetic foot ulcer.
Number of foot ulcersAt each clinic visit through study completion, an average of 8 monthsThe number of diabetic foot ulcers.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMuturi G. Muriuki, PhD

Edward Hines Jr. VA Hospital, Hines, IL

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026